EcoDrugPlus

Carbonic Anhydrase 6

Ensembl ID : ENSDLAG00005022106
Gene Symbol: CA6
1 Cross references
227 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSDLAG00005033961
Gene Symbol: CA4A
1 Cross references
215 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSDLAG00005000273
Gene Symbol: CA4C
1 Cross references
201 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSDLAG00005023838
Gene Symbol: CA7
1 Cross references
222 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSDLAG00005012475
Gene Symbol: CSNK1E
1 Cross references
205 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSDLAG00005017730
Gene Symbol: CTSC
1 Cross references
239 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSDLAG00005014479
Gene Symbol: CTSK
1 Cross references
226 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSDLAG00005014499
Gene Symbol: CTSS2.1
1 Cross references
235 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSDLAG00005008315
Gene Symbol: CDC7
1 Cross references
209 Possible Orthologues:

Chemokine (C-X-C Motif), Receptor 4b

Ensembl ID : ENSDLAG00005021633
Gene Symbol: CXCR4B
1 Cross references
216 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSDLAG00005021893
Gene Symbol: CCKBRA
1 Cross references
198 Possible Orthologues:

Cholesteryl Ester Transfer Protein, Plasma

Ensembl ID : ENSDLAG00005014863
Gene Symbol: CETP
1 Cross references
151 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).